Introduction {#Sec1}
============

Mesenchymal stem cells have become a therapeutic option for several pathologies like myocardial infarction, osteogenesis imperfecta, graft versus host disease and wound healing \[[@CR1]--[@CR4]\]. As a part of the cell therapy, MSC are often transplanted in ischemic, apoptotic and/or inflammatory environments where cells survive and promote tissue regeneration by mechanisms that remain poorly understood. These cells are immunoprivileged, and in most of pathologies the induced potential benefits are related to paracrine activity mediated by their ability to survive in ischemic and inflammatory environments \[[@CR5]--[@CR7]\]. Despite their therapeutic potential initial, clinical results have been disappointing due to reported low benefits. It is believed that in adequate doses, low engraftment and poor survival are responsible for these results. We and others reported that intramyocardial MSC transplantation recruits a number of inflammatory cells that contribute to the healing of the infarct \[[@CR8], [@CR9]\]. Transplanted cells are consistently exposed to tissue signals, immune cells and mediators that could influence their behaviour. Since successful application of stem cell approaches will depend on the microenvironment of the recipient tissue, we have sought to investigate the response of MSC to an inflammatory environment. Previous reports showed that proinflammatory cytokines were able to increased migration of human MSC to many chemotactic factors \[[@CR10]\], to induce MSC to produce chemokines \[[@CR11]\] and to stimulate MSC to differentiate into neural phenotype \[[@CR12]\]. Following this rationale we cultured MSC in the presence of inflammatory mediators and analyzed biological responses implicated in proliferation, survival, adhesion and migration that could aid to predict their response in these environments. We focused our studies in IL-1β as a prototypical inflammatory mediator and the results showed that this cytokines promotes specific biological processes in MSC in part due to activation of the transcription factor NF-κB (Nuclear Factor KAPPA-light-chain-enhancer of activated B cells).

Materials and Methods {#Sec2}
=====================

Cells and Culture Conditions {#Sec3}
----------------------------

Human bone marrow MSC (*n* = 4; Inbiomed, San Sebastian, Guipuzcoa, Spain) were cultured following manufacturers´ instructions. After centrifugation cells were seeded in tissue culture flasks in low glucose Dulbecco's modified Eagle medium (Sigma-Aldrich, St. Louis, MO; [htpp://www.sigmaaldrich.com](http://htpp://www.sigmaaldrich.com)), supplemented with 10% fetal calf serum (Thermo Scientific Hyclone, Rockford, IL; [htpp://www.piercenet.com](http://htpp://www.piercenet.com)), 4 mM L-Glutamine (Gibco, Grand Island, NY; [htpp://www.invitrogen.com](http://htpp://www.invitrogen.com)) and 1% antibiotics \[50U/mL penicillin, 50 μg/mL streptomycin (Gibco)\]. Cells were maintained in a humidified atmosphere of 95% air and 5% CO2 at 37°C. The medium was replaced every 3 days. IL-1β (25 ng/mL), (Millipore, Temecula, CA; [htpp://www.milipore.com](http://htpp://www.milipore.com)), IL-6 (20 ng/mL), (R&D Systems, McKinley Place, MN; [htpp://www.RnDSystems.com](http://htpp://www.RnDSystems.com)), IL-8 (20 ng/mL), (Sigma-Aldrich) and TNF-α (50 ng/mL), (Sigma-Aldrich) were added and maintained during different periods of time depending on the experiments.

Electrophoresis and Western blotting {#Sec4}
------------------------------------

Cells were submitted to serum deprivation for 18 h before incubation with IL-1β (25 ng/mL) for 30 min. Cells were then washed with PBS and the monolayer lysed in M-PER® Mammalian Protein Extraction Reagent (Thermo Fisher Scientific, Rockford, IL; [htpp://www.piercenet.com](http://htpp://www.piercenet.com)) containing protease inhibitors (Roche, Mannheim, Germany; [htpp://www.roche.com](http://htpp://www.roche.com))\] and phosphatase inhibitors \[Sodium Orthovanadate 1 mM (Sigma-Aldrich), Sodium Fluoride 1 mM (Sigma-Aldrich)\]. Protein concentration was quantified using the Pierce® BCA Protein Assay Kit (Thermo Fisher Scientific). For western blotting 30 μg of protein was loaded and separated by 10% SDS-PAGE, before transfer to a PVDF membrane (Thermo Scientific) and blockinged with 5% BLOT-Quick Blocker (Millipore). Primary antibodies were incubated at 4°C overnight. After, the blots were incubated with IgG HRP Conjugated for 1 h at room temperature. Detection was performed with ECL system \[ECL Plus^TM^ Western Blotting Detection Reagents Amersham (GE healthcare, Bukinghamshire, UK; [htpp://www.gehealthcare.com](http://htpp://www.gehealthcare.com))\]. GAPDH was used to determine equal protein loading. Antibodies used were anti-phospho-Akt 1/2/3 (Ser473), anti-phospho-NFκβ p65 (Ser536) (Cell Signaling Tecnology Inc., Danvers, MA; [htpp://www.cellsignaling.com](http://htpp://www.cellsignaling.com)), anti-GAPHD, anti-ERK 1/2 (MAPK), anti-phospho-ERK 1/2 (MAPK), (Chemicon, Temecula, CA; [htpp://www.chemicon.com](http://htpp://www.chemicon.com)), anti-Akt 1/2/3, anti-NFκβ(p65), anti-rabbit IgG HRP Conjugated (Santa Cruz Biotecnology Inc., Santa cruz, CA; [htpp://www.scbt.com](http://htpp://www.scbt.com)) and anti-mouse IgG HRP Conjugated (Promega, Madison, WI; [htpp://www.promega.com](http://htpp://www.promega.com)). All antibodies used were assayed at 1:1,000 dilution except anti-Akt 1/2/3 and anti-NFκB (p65) that were used at 1:500.

Cell Cycle Assay {#Sec5}
----------------

To analyze the effect of IL-1β in cell cycle, 10^6^ cells were harvested, fixed with 70% EtOH and kept at −20°C until use. Fixed cells were centrifugated and resuspended in 50 μg/mL propidium bromide (Sigma-Aldrich) and analyzed by flow cytometry (488 nm excitation, 625 nm emission).

MTT Proliferation Assay {#Sec6}
-----------------------

Cell proliferation was determined using a 3-(4, 5-dimethylthiazol-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. MSC were plated at a density of 10^4^ cells/cm^2^ in 96-well microplates. 24 h post seeding, cells were treated with recombinant IL-1β (25 ng/mL) or IL-6 (20 ng/mL) for 24 h. Proliferation was assayed by Thiazolyl Blue Tetrazolium Bromide (Sigma-Aldrich), acording to manufacturer´s instructions. The absorbance of the samples was measured at 570 nm using a microplate reader (Victor3 1420 Multilabel Counter; PerkinElmer Inc., Waltham, MA; [htpp://www.perkinelmer.com](http://htpp://www.perkinelmer.com)). Experiments were performed in triplicate and results were expressed relative to the untreated control.

Construction of IKKβ shRNA and Lentiviral Transduction {#Sec7}
------------------------------------------------------

IKKβ shRNA secuences have been published previously \[[@CR13]\] and were purchased from Sigma-Genosys (Sigma-Aldrich): - IKKβi: GGAAGTACCTGAACCAGTTTG. Oligos were annealed and cloned into pSUPER plasmid carrying H1 promoter using BglII-HindIII sites. The H1-shRNA expression cassette was then excised and cloned into pLVTHM (Addgene plasmid 12247; Addgene, Cambridge, MA, <http://www.addgene.org>) using EcoRI-ClaI sites. Viral particles were produced in human embryonic kidney 293 T cells (ATCC, [www.atcc.org](http://www.atcc.org)). Briefly, 293 T cells were seeded in high glucose DMEM containing 10%FBS. psPAX (Addgene plasmid), pVSV-G (Addgene plasmid 12259, [www.addgene.org](http://www.addgene.org)) and the lentiviral vector pLVTHM containing GFP reporter gene and shRNA sequences were transfected in to the packing cells using calcium phosphate precipitation method. Viral transduction was carried out using a multiplicity of infection (M.O.I.) of 10 in the presence of 8 μg/mL of polybrene (Sigma-Aldrich) in order to achieve 100% infection.

MSC Migration Assay {#Sec8}
-------------------

To study trophism induced in MSC by IL-1β, cells were seeded in basal medium (DMEM with 0.5% FBS) at 10,000 cells/cm^2^ in the top chamber of an 8 μm-pore migration transwell (BD Falcon, Bedford, MA, [htpp://www.bd.com](http://htpp://www.bd.com)). After overnight culture, 25 ng/mL of IL-1β was added to the bottom chamber and cells were fixed with 2% paraformaldehide (Panreac Química, Castellar del Vallés, Spain), SDF-1α (20 ng/mL) and 10% FBS were used as positive controls. Briefly, after 4 h non migrated cells were removed from the upper side of the membrane using a cotton bud to remove non migrating cells, the membrane was cut and placed in a glass slide with the bottom side upwards and before staining with 4´,6 diamidino-2 phenyilindole (DAPI) (Sigma-Aldrich). All assays were performed in duplicated wells and repeated three times. Migrated cells were counted as fold increase relative to passive MSC cell migration in untreated wells.

Leucocyte Migration Assay {#Sec9}
-------------------------

To determine the nature of human leucocytes that could be recruited in response to paracrine factors secreted by MSC, we established co-culture of MSC and pheripheral blood leucocytes (PBLs) using a transwell culture system (BD Falcon). MSC (10,000 cells/cm^2^) seeded in the lower chamber of the transwells were stimulated or not with IL-1β for 2 h. After extensive washes with PBS, wells were filled with fresh medium and human PBLs from buffy coats (100,000 cells) were seeded in the upper chamber. Migrated cells through 8 μm-pore size membranes were counted after 5 h of co-culture. Cells were fixed as described above and leucocyte populations were quantified in hematoxilin stained preparation by morphologic counting. All studies were performed in a blinded fashion.

Adhesion Assay {#Sec10}
--------------

Cells were seeded in basal medium onto cover slides previously treated with 10 μg/cm² of fibronectin (Sigma-Aldrich), 2 μg/cm² of laminin (Sigma-Aldrich) and 10 μg/cm² of collagen (Sigma-Aldrich). After 1 h, cells were fixed with 2% paraformaldehyde, washed with PBS, labelled with 4´,6-diamidino-2-phenylindole (DAPI) and counted.

Reverse Transcription and Real-Time Quantitative PCR {#Sec11}
----------------------------------------------------

MSC incubated in different conditions were washed with PBS. RNA was extracted using TRIzol Reagent (Invitrogen, Carlsbad, CA; [htpp://www.invitrogen.com](http://htpp://www.invitrogen.com)) and purified with RNeasy Plus Mini Kit (Qiagen, Dusseldorf, Germany; [htpp://www.qiagen.com](http://htpp://www.qiagen.com)). RNA samples were quantified by spectrometry (NanoDrop ND-1000, NanoDrop Technologies, Wilmington, DE; [htpp://www.nanodrop.com](http://htpp://www.nanodrop.com)) and integrity was assessed by agarose gel electrophoresis and the absorbance ratio 260/280 nm. cDNA was obtained by retrotranscriptase reverse transcription using M-MLV Reverse Transcriptase (Invitrogen) from total RNA (1 μg). Primers were designed using the Primer-Blast online tool (Table [1](#Tab1){ref-type="table"}). The Ct of each PCR in a reference human MSC cDNA sample (dilution 1/10) is expressed as mean ± standard deviation (SD) of three independent PCR experiments. Real-time PCR was performed using convenient primers and SYBR Green I \[1X LightCycler 480 SYBR Green I Master (Roche Molecular Biochemical, Mannheim, Germany; [htpp://www.roche.com](http://htpp://www.roche.com))\]. Plates were run in a real-time thermal cycler (LightCycler 480 Instrument; Roche Diagnostics, Mannhein, Germany, [htpp://www.roche.com](http://htpp://www.roche.com)) following manufacturer´s instructions. Real-time monitoring of the PCR reaction was performed with the LightCycler 480 Software 1.5, as well as the quantification of the products in the exponential phase of the amplification. Relative expression levels were calculated with the Relative Quantification Analysis software. Results were considered to be significant with a 2-fold induction. For all real-time experiments, gene expression levels were normalized to two human housekeeping genes ACTB and GAPDH and average from triplicate samples.Table 1List of oligonucleotides used for Real time-PCR. Ct and efficiency values are indicatedGeneForward primerReverse primerSize (bp)CtSD CtEfficency^a^ACTBAGAGCCTCGCCTTTGCCGATCCCATGCCGGAGCCGTTGTCGAC10116.100.0251.971CCL2TCTCAGTGCAGAGGCTCGCGACCACTTCTGCTTGGGGTCAGCAC11917.010.0061.977CCL3TTCAGAAGGACACGGGCAGCAGACAGGAATCTGCCGGGAGGTGTAGCT21629.640.0501.862CCL5TACATTGCCCGCCCACTGCCGGGTTGGCACACACTTGGCG11923.820.0522.061CCL7CAGCTGCTTTCAGCCCCCAGGGCTTCCCGGGGACAGTGGCTA14823.930.0321.923CCL8TGGCAGCCACTTTCAGCCCTGCACAGACCTCCTTGCCCCG19027.980.1672.040CCL20TCTGCGGCGAATCAGAAGCAGCTTCATTGGCCAGCTGCCGTGT11021.190.0682.16CLDN1CCGGGTTGCCCACCTGCAAACGTACATGGCCTGGGCGGTC25824.490.1481.862CLDN14GTCGCTGTGGGCAGGTGGTCAGCCTCCCCTTCCCAGCCTG19230.480.0932.084CSF2TGCAGCATCTCTGCACCCGCAGGCAGGTCGGCTCCTGGAG17624.470.1881.708CSF3AGACCCATGGCTGGACCTGCCGTGGCACACTCACTCACCAGCTTC21831.560.0432.026CX3CL1CTGGCTGGACAGCACCACGGGCTCCTTCGGGTCGGCACAG17525.960.0871.880CXCL1AGCCTGCAACATGCCAGCCATGTGCACATACATTCCCCTGCCT9421.720.0361.848CXCL10TGCAAGCCAATTTTGTCCACGTGTGCAGCCTCTGTGTGGTCCATCC20024.100.0511.956CXCL11TGTCTTTGCATAGGCCCTGGGGTAGCCTTGCTTGCTTCGATTTGGGA16429.720.1781.821CXCL3AATGTAAGGTCCCCCGGACCCCACCACCCTGCAGGAAGTGTCAA19920.920.0362.023CXCL5AATCTCCGCTCCTCCACCCAGTGCTCTCTCAACACAGCAGCGGC20128.490.0501.614CXCL6GCACGAGGAAACCAAAGTGCTCTGGTGCAACGCAGCTCTGTCAGCA23426.370.0711.890ELF3ATTTAGAGCCGGGTAGGGGAGCGGTTGCAGCCATGAGGCTACCGGAGT13225.680.0881.912GAPDHCCCCTCTGCTGATGCCCCCATGACCTTGGCCAGGGGTGCT12216.790.0151.998IBSPGGAGTACGAATACACGGGCGCCGGTAGCCGGATGCAAAGCCAGA22227.120.0492.018ICAM1CTGGTCCTGCTCGGGGCTCTGGGCTGGTCACAGGAGGTGC12622.420.0941.638ICAM4AATACACTTTGCGCTGCCACGTGGGCTCCAAGCGAGCATCAGTGT26428.160.1162.057IL11TGACCCGCTCTCTCCTGGCGGCACGTGCCGCAGGTAGGAC19224.230.1631.803IL12ACCCAAAACCTGCTGAGGGCCGTGGAGGCCAGGCAACTCCCAT21929.080.0471.985IL15GCTGCTGGAAACCCCTTGCCATTAGGTGCTTTGGGCCAACTGGG21428.780.0351.899IL1BAGGCACAAGGCACAACAGGCTAACAACTGACGCGGCCTGCC27721.120.1101.965IL23ATGGCTGTGACCCCCAAGGACTCTGCCATGGCTGGCTGGGACT24627.010.0531.893IL32TTTGTGCCAGGAAGACTGCGTGCGGCTCGACATCACCTGTCCACG21524.410.0782.004IL34GAACACCACCATGCCCCGGGCAGCCTGGTGACGTTGGCGA25024.590.0781.853IL6CATTCTGCCCTCGAGCCCACCGGCAGCAGGCAACACCAGGA13917.080.0881.955IL7GCTGCTCGCAAGTTGAGGCAATTTTTGTTGGTTGGGCTTCACCCAGG15726.580.2131.974IL8CGTGGCTCTCTTGGCAGCCTTCTTCCTTGGGGTCCAGACAGAGCTC22915.880.7072.005ITGA9GCAGTGACCGCTGGCCACTTGCGCACAAGGAGGAGCCGAA18227.630.0981.969ITGB3TGCCGCCCTGCTCATCTGGATCCTGCAATCGTGGCACAGGC23922.430.0082.192ITGB8CTAGCGACACTCGGCCCGCCTGGACCCAGCGCAAGGCAC29227.760.0231.850MMP1GTGTCTCACAGCTTCCCAGCGACGCACTCCACATCTGGGCTGCTTC23825.010.0842.006NOD2AGGCCTACCCGCAGATGCCAGTGGGAGAGAGGCTGGCCCA29828.040.1722.062SDC4CGGAGTCGCCGAGTCGATCCGGCTCCCAGACCCTGCCCTC24820.510.0301.925SELECTINTTGTTCCTGCCAGCAGCTGCCAGGGCCAGAGACCCGAGGAG16417.640.0852.030SERPINE1AGGACGAACCGCCAATCGCAAGACCCTCACCCCGAAGTCTGAGG16725.860.0342.120TCAM1PCGAGCTTGGCTGTGGCCTCCTCTCCGCCATCCCAGCCTCC22527.050.0781.856TLR2AGGCAGCGAGAAAGCGCAGCCCCCCAAGACCCACACCATCCA25331.230.3522.162TLR4CCCTGCGTGGAGGTGGTTCCTACTCCCAGGGCTAAACTCTGGATGGG28026.450.0242.007TNFCCCTCTGGCCCAGGCAGTCAATGGGTGGAGGGGCAGCCTT23521.580.0192.100VCAM1AGGTGACGAATGAGGGGACCACACCAGCCTCCAGAGGGCCACT18117.310.0102.039^a^PCR efficiency of each PCR was estimated from a serially diluted standard curves obtained from a reference MSC cDNA sample. The cycle number of the crossing point CP vs. Log (dilution factor) were plotted to calculate the slope. The efficiency of each PCR was then calculated with the equation $\documentclass[12pt]{minimal}
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Microarray Assays {#Sec12}
-----------------

Human bone marrow MSC were treated or not with IL-1β (25 ng/mL) for 24 h at 37°C in a humidified incubator with 5% CO2. Cells were collected and total RNA was extracted using the High Pure RNA Isolation kit (Roche) and quantified by spectrometry (NanoDrop ND-1000, NanoDrop Technologies). 800 ng of total RNA were used to produce Cyanine 3-CTP-labeled cRNA using the Low RNA Input Linear Amplification Kit PLUS (Agilent, Santa Clara, CA¸ <http://www.chem.agilent.com>). Based on the protocol for One-Color Microarray-Based Gene Expression Analysis Version 5.5 (Agilent p/n 5188--5977), 3 μg of labeled cRNA was hybridized with Whole Human Genome Oligo Microarray Kit (Agilent p/n G4112F) containing 41,000+ unique human genes and transcripts. Arrays were scanned in an Agilent Microarray Scanner (Agilent G2565BA) according to the manufacturer's protocol and data extracted using Agilent Feature Extraction Software 9.5.1. Hybridization was performed by the microarray core facility from Centre Principe Felipe.

Microarray Data Analysis {#Sec13}
------------------------

Signal was standardized across arrays using quantile normalization \[[@CR14]\]. Differential gene expression was carried out using the fold change. Gene set analysis was carried out for the Gene Ontology terms using FatiScan \[[@CR15]\] from Babelomics web tool \[[@CR16]\]. GO annotation for the genes in the microarray where taken from Ensembl 55 release (<http://www.ensembl.org>, Ensembl org, Hinxton, UK), allowing the visualization of functional categories within their biological context. Results were considered to be significant with a 2-fold induction.

The microarrays data of this study have been deposited in the Gene Expression Omnibus database under accession number GSE33755.

Statistical Analysis {#Sec14}
--------------------

Data are expressed as mean ± SD. Comparisons between experimental groups were done with unpaired and paired two-samples t-test using the SPSS software (SPSS, Chicago, IL <http://www.spss.com>). Differences were considered statistically significant at *P* \< 0.05.

Results {#Sec15}
=======

Global Transcriptome Profiling of MSC Cultured with IL-1β {#Sec16}
---------------------------------------------------------

To test the effect of IL-1β on MSC, cells were cultured with or without 25 ng/mL of IL-1β for 24 h. Gene expression changes induced by the pro-inflammatory cytokine were evaluated by microarray analysis. Further bioinformatics analysis using Babelomics software (<http://www.babelomics4.org>) was performed to classify genes by function using the Gene Ontology (GO) scheme, revealing the main families of genes affected by the treatment. Growth in IL-1β resulted in activation of genes associated to very specific GO categories. In particular, we identified alterations in the expression of genes implicated in the following biological processes: i) response to wounding, ii) immune and inflammatory response, iii) defense response, iv) chemotaxis, v) locomotory behaviour, vi) regulation of cell proliferation, vii) leukocyte chemotaxix, viii) I-kappaB kinase/NF-kappaB cascade, ix) negative regulation of apoptosis, x) blood coagulation, and xi) cell adhesion (Table [2](#Tab2){ref-type="table"}). Fold changes of up-regulated genes (negative values) from enriched biological processes in MSC treated with IL-1β (MSC-IL1β) are indicated (Supplemental Table [1](#MOESM1){ref-type="media"}).Table 2Enriched biological processes for up-regulated genes in MSC-IL1β versus MSCGO biological processProcess gene set*P* valueGO:0009611Response to wounding2.00E-21GO:0006955Inmune response1.74E-19GO:0006954Inflammatory response2.43E-18GO:0006952Defense response2.43E-17GO:0006935Chemotaxis5.44E-10GO:0007626Locomotory behavior6.15E-9GO:0042127Negative regulation of cell proliferation1.27E-5GO:0030595Leukocyte chemotaxis3.04E-3GO:0007249I-kappaB kinase/NF-kappaB cascade3.27E-3GO:0043066Negative regulation of apoptosis3.64E-3GO:0007596Blood coagulation1.36E-2GO:0007155Cell adhesion3.26E-2

IL-1β Increases Expression of Multiple Chemokines and Growth Factors in MSC {#Sec17}
---------------------------------------------------------------------------

After bioinformatic analysis, highly up-regulated genes related with these biological processes were further assayed by real-time PCR (Fig. [1](#Fig1){ref-type="fig"}, Table [3](#Tab3){ref-type="table"}). Chemokines are small molecules that direct the migration of immune cells via chemokine-chemokine receptor interactions. Based on their genetic organization and the position of two highly conserved cysteine residues at the N-terminus, chemokines can be divided into four subgroups, the CC, CXC, C, and CX~3~C families \[[@CR17]\]. Among CC chemokines, CCL5 and CCL20 were the most up-regulated in response to IL-1β treatment (312 ± 27 and 187 ± 15 fold, respectively). CXCL1, CXCL3 and CX~3~CL1 were also highly expressed after IL-1β treatment. CXCL10, CXCL11 and ELF3 were expressed de novo upon stimulation of MSC with IL-1β (Table [3](#Tab3){ref-type="table"}). Regarding the cell adhesion molecules, the most important families include the intercellular adhesion molecules (ICAMs), the vascular adhesion molecules (VCAMs), cadherins, and selectins. Among them, IL-1β treatment increased expression of the integrin binding sialoprotein (IBSP), ICAM1, ICAM4, integrin beta 3 platelet glycoprotein IIIa (ITGB3), TCAM1P and VCAM1 as detected by real-time PCR (Fig. [1](#Fig1){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}). Other adhesion molecules also showed a significant fold detected by microarray analysis (Supplemental Table [1](#MOESM1){ref-type="media"}).Fig. 1Quantification of gene transcription levels by qRT-PCR analysis in MSC cultures treated with IL-1β versus untreated cultures. Data are expressed as relative fold of control (normalized values) and represent the mean ± S.D. of three independent experimentsTable 3Transcriptional levels of up-regulated genes in MSC after treatment with IL-1β. Normalized values of MSC-IL1β vs non-treated MSC were calculated and expressed as mean ± standard deviation (SD) of three independent PCR experimentsChemokinesGenebank numberMean CtSD CtNormalized valuesNormalized ErrorCXCL1NM_00151121.720.03689.15.9CXCL3NM_00209020.920.03615411CXCL5NM_00299428.490.0508.650.59CXCL6NM_00299326.370.07116.51.27CXCL10NM_00156524.100.0512028127CXCL11NM_00540929.720.17841.33.07CX3CL1NM_00299625.960.08721.10.76CCL2NM_00298217.010.00613.10.46CCL3NM_00296329.640.05029.215.8CCL5NM_00298523.820.05231227CCL7NM_00627323.930.03213.10.90CCL8NM_00562327.980.16712.21.00CCL20NM_00459121.190.06818715Adhesion molecules Selectin ENM_00045017.640.0850.940.08 VCAM-1NM_001078.317.310.0105.330.19 ICAM-1NM_00020122.420.09424.50.84 ICAM-4NM_001544.328.160.11687.49.1 Syndecan 4NM_002999.320.510.0301.450.05 IBSPNM_004967.327.120.0496.211.64 ITGA9NM_002207.227.630.0980.810.05 ITGB3NM_000212.222.430.0082.750.11 ITGB8NM_002214.227.760.0231.240.07 TCAM-1NR_002947.127.050.0782.170.12Interleukines IL1NM_000576.221.120.11014541 IL6NM_000600.317.080.0889.991.12 IL7NM_000880.326.580.2131.290.27 IL8NM_000584.315.880.7077614.4 IL11NM_000641.224.230.1630.790.18 IL12ANM_000882.329.080.0471.160.05 IL15NM_172175.228.780.0352.940.48 IL23ANM_016584.227.010.05325.37.8 IL32NM_001012631.124.410.07814.80.81 IL34NM_152456.224.590.0783.121.44Growth factors TNFNM_00059421.580.01924321 CSF2NM_00075824.470.18839.313.2 CSF3NM_00075931.560.0431.160.03 ELF3NM_00443325.680.08865645Toll-like receptors Claudin 1NM_021101.424.490.1485.490.23 Claudin 14NM_144492.230.480.0931.300.13 NOD2NM_022162.128.040.171.230.11 TLR2NM_003264.331.230.3522.290.12 TLR4NM_138554.326.450.0241.500.16Metalloproteins MMP1NM_002421.325.010.08416212 MMP3NM_002426.416.560.65047.57.02

Treatment with IL-1β influenced the secretion of interleukins and growth factors. The highest differences in fold change were found in TNF-α, followed by IL-8 and CSF2 levels (Fig. [1](#Fig1){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}). Whereas TNF-α is a master inflammatory cytokine implicated in many biological process, IL-8 and CSF2 have more restricted biological activities. Indeed, IL-8 has been predominantly associated to chemotaxis of neutrophils \[[@CR18]\] whereas CSF2 is implicated in monocytic differentiation \[[@CR19]\].

Other biological processes activated in response to IL-1β were related to host defence and immune response. Microarray analysis and real time PCR experiments showed up-regulation of several Toll-like receptors (TLRs), claudins and NOD proteins. These molecules are implicated in the innate immune response to microbial infection. However, recent reports have revealed that these molecule also modulates biological processes in MSC such as differentiation, migration and immunomodulatory responses \[[@CR20], [@CR21]\].

IL-1β Activates the NF-κB Pathway and do not Induce MSC Proliferation {#Sec18}
---------------------------------------------------------------------

We next analyzed the effect of IL-1β on BM-MSC signal transduction and cell proliferation. IL-1β promoted phosphorylation of NF-κB, but not PI3K/AKT and ERK1/2 pathways (Fig. [2a](#Fig2){ref-type="fig"}), as reported for other cell types \[[@CR22]\]. However, in correlation with the result of the microarray analysis (Table [2](#Tab2){ref-type="table"}), IL-1β did not induce significant cell proliferation as assessed by MTT assay (Fig. [2b](#Fig2){ref-type="fig"}). These results were further confirmed by cell cycle analysis using flow cytometry (Fig. [2c](#Fig2){ref-type="fig"}). The percentage of cells in G0-G1 was 91.16 ± 2.71 in MSC versus 90.19 ± 2.72 in MSC- IL-1β. The percentage of cells in S phase was 2.28 ± 1.21 in MSC versus 1.60 ± 0.46 in MSC- IL-1β, and finally the percentage of cells in G2-M phase was 5.43 ± 1.16 versus 6.40 ± 1.69, respectively.Fig. 2**a**, Western blot analysis of kinase phosphorylation in MSC treated with IL-1β. Total cell lysates (30 μg) were separated by SDS-PAGE. Anti-GAPDH was used as loading control. **b**, MTT assay of MSC cultures treated with IL-1β (25 ng/mL) and IL-6 (20 ng/mL) for 24 h. Values are expressed in fold increase relative to control. **c**, Cell cycle analysis by flow cytometry of MSC cultures treated with IL-1β (25 ng/mL) for 24 h. (\**P* \< 0.05)

IL-1β Induced Migration and Adhesion of MSC is Mainly Activated Through NF-κB Signaling {#Sec19}
---------------------------------------------------------------------------------------

We and others have previously described that MSC are able to migrate *in vivo* to ischemic and pro-inflammatory environments \[[@CR8], [@CR23], [@CR24]\] and it is believed that this behaviour may underlie the ability of these cells to accelerate wound healing. Migration of MSC towards cytokines, chemokines and growth factors has also been explored *in vitro* \[[@CR10]\]. To test if IL-1β was able to increase migratory ability in MSC, we cultivated MSC in the upper chamber of a transwell and stimulated migration by adding SDF-1α, IL-1β or 10% FBS in the lower chamber (Fig. [3a](#Fig3){ref-type="fig"}). A negative control of for migration was achieved using the same proportion of fetal bovine serum (0.5% FBS) in the upper and lower chamber. SDF-1α was used since it is a well-known trophic factor for MSC implicated in homing to ischemic areas \[[@CR24]\], and 10% FBS was used as positive control since it is a rich source in cytokines and growth factors. Surprisingly, the migratory response of MSCs to IL-1β was in fact more pronounced than it was to to SDF-1α (1.68 ± 0.21 fold increase versus 1.35 ± 0.16), indicating a strong promigratory role for IL-1β Maximum migration was achieved towards FBS gradient (1.87 ± 0.12 fold increase). Similar levels of cell migration were observed when TNF-α or IL-8 were used as trophic factors (not shown), indicating that multiple inflammatory mediators can exert trophic effects on MSC as reported \[[@CR24]\]. We next wanted to investigate whether the signaling pathways induced by IL-1β could be directly linked to MSC migration towards trophic factors. NF-κB transcription factors play an important role in the balance between cell survival and apoptosis and are involved in the regulation of cell proliferation and differentiation of various cell types \[[@CR25]\]. IKKβ phosphorylates IκB molecules, the inhibitors of NF-κB, leading to ubiquitination and proteasome degradation of the inhibitors, and hence release and activation of NF-κB \[[@CR26]\]. NF-κB has previously been described as the main transcription factor activated in many pro-inflammatory responses \[[@CR27]\]. In these context, regulation of NF-κB cascade members was observed among the biological processes most positively affected by IL-1β treatment (Table [2](#Tab2){ref-type="table"}) and phosphorylation of NF-κB was induced on MSC after IL-1β treatment (Fig. [2](#Fig2){ref-type="fig"}). Thus, we sought to evaluate the role of NF-κB signaling in the biological responses of MSC in response to IL-1β. For this purporse, we constructed a vector containing shRNA targeting IKKβ that was lentiviraly transduced in MSC. We then evaluated the migratory response to IL-1β, SDF-1α and FBS. As shown in Fig. [3a](#Fig3){ref-type="fig"}, treatment with IKKβ shRNA reduced trophic response of MSC towards each of the 3 trophic factors assayed. An increase in the basal response of IKKβ transduced cells of 1.05 ± 0.11 fold was observed, and in response to trophic factors this was increased by 1.21 ± 0.11 towards SDF-1α, 1.45 ± 0.06 towards IL-1β, and 1.58 ± 0.07 towards 10% FBS, strongly suggesting that NF-κB signaling pathway plays a major role in MSC trophism.Fig. 3**a**, migration of MSC or MSC-IKKβ towards trophic factors SDF-1α (20 ng/mL), IL-1β (25 ng/mL) and 10% FBS. **b**, Adhesion of untreated MSC (black bars) and MSC-IKKβ (*dashed bars*) or treated with IL-1β (white and grey bars, respectively) to collagen, fibronectin and laminin. Data are represented as fold increase relative to MSC control. (\**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001 in both panels)

Migration and invasiveness of adherent cells is in part mediated by changes in the affinity of cells to particular ECM components (ECM). To test whether IL-1β had an effect on MSC cell adhesion, we measured the adhesion of MSC to the main components of ECM. The results showed that IL-1β treatment increased the adhesion to collagen (3.03 ± 0.29 fold), fibronectin (1.75 ± 0.11 fold) and laminin (2.79 ± 0.15 fold) (Fig. [4b](#Fig4){ref-type="fig"}). In similar way to migration experiments, adhesion induced by IL1β treatment to collagen (1.75 ± 0.15 fold), fibronectin (1.20 ± 0.05 fold) and laminin (1.32 ± 0.07 fold) was impaired in IKKβ-MSC. The fact that IKKβ expression only affected the adhesion induced by IL-1β but not the basal levels of adhesion to extracellular matrix components indicates that IKKβ blocks specifically the mechanisms induced by this cytokine, confirming the importance of NF-κB signaling pathway in the IL-1β mediated biological processes.Fig. 4Leucocyte migration assay of human PMNs using a transwell insert culture system towards different stimuli. Upper chamber were filled with PMNs and lower chambers were seeded with MSC (*black bars*) or MSC-IKKβ (*white bars*) treated (dashed and grey bars, respectively) or not with IL-1β. Migrated neutrophils, eosinophils, lymphocytes and monocytes are presented as a mean of three experiments ± S.D. (number of migrated cells/field). \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001

Il-1β Treatment of MSC Increases Recruitment of Leucocytes In Vitro {#Sec20}
-------------------------------------------------------------------

MSC have been shown to recruit inflammatory cells such as neutrophils, eosinophils, macrophages and to suppress proliferation of cytotoxic and helper T cells through the release of soluble factors such as HGF and TGF-β \[[@CR11], [@CR28]--[@CR30]\]. Moreover, infusion of MSC into myocardium and other tissues is accompanied by marked, paracrine mediated leucocytic infiltration \[[@CR4], [@CR8]\]. In order to test whether IL-1β treatment had a similar impact in MSC leucocyte recruitment, we cultured control or IL-1β treated MSCs, in a transwell system and measured the number and the type of leucocytes that migrate through a the 8 μm pores of the membrane. After 5 h of culture, the mean number of migrated leucocyes/field towards the MSC lower chambers were; 12.06 ± 2.91 neutrophils, 6.52 ± 2.14 eosinophils, 4.40 ± 2.41 lymphocytes and 3.15 ± 1.34 monocytes. However, migration towards IL-1β treated MSCs increased the number of migrated neutrophils (16.11 ± 2.75, *P* \< 0.05), eosinophils (10.44 ± 2.61, *P* \< 0.01), lymphocytes (6.31 ± 2.68, n.s.) and monocytes (9.85 ± 2.94, *P* \< 0.001) (Fig. [4](#Fig4){ref-type="fig"}). The observed increase in chemotactic leucocyte migration induced by IL-1β treated MSC was again impaired when MSC were transduced with IKKβ (9.78 ± 2.29 neutrophils, 5.52 ± 1.74 eosinophils, 3.42 ± 1.98 lymphocytes and 2.68 ± 1.45 monocytes). Thus, IL-1β induced recruitment of neutrophils, eosinophils and monocytes and NFκB plays a mayor role in trophism exerted by MSC on these cell populations.

Discussion {#Sec21}
==========

MSC have been used to treat a wide variety of diseases. Whilst the contribution of differentiation/transdifferentiation to tissue repair, are often minimal, other positive angiogenic and immunomodulatory effects are exerted by MSC in ischemic, apoptotic and pro-inflammatory environments \[[@CR6]\].

IL-1β is produced in different tissues, not only as a response to pathogens, but also as a danger signals in pathologies such as acute myocardial infarction \[[@CR31]\], type 2 diabetes \[[@CR32]\], neural disorders \[[@CR33]\]. In this study we wanted to investigate the response of MSC to proinflammatory stimuli in terms of survival, proliferation and induced paracrine factors. Thus, we treated MSC with IL-1β and used microarray to infer the biological response, firstly by gene function and later by direct gene set with known functional outcomes. A range of biological responses were activated in response to IL-1β, but perhaps, the most prominent was the potent stimulation of secretion of chemokines and growth factors that in turn were able to increase migration and adhesion of MSC and to regulate recruitment of monocytes and granulocytes. It is known that members of the CC family target primarily monocytes and T cells, whereas CXC chemokines affect mainly neutrophils. It has been previously reported that the existence of different monocyte subsets expressing different chemokine receptors display distinct migratory and functional properties. Interestingly, the profile by MSCs in response to chemokines secreted IL-1β, was enriched in CCL5, CCL20 and CX3CL1, that could specifically attract not only neutrophils and monocytes, but also monocytes expressing CCR5, CCR6 and high levels of CX3CR1 \[[@CR34]\]. Although leukocyte chemotaxis and lymphocyte development are the main functional properties of chemokines, they posses other biological activities like regulation of angiogenesis, control of cell proliferation and alteration of the expression of adhesion molecules. Indeed, the structural ERL domain present in several members of the CXC chemokine family determines their angiogenic potential \[[@CR35]\] and the induced chemokquines CXCL1, CXCL3, and CXCL8 (IL-8) contain this motif. In the same context, CXCL10 is considered a "stop signal" that limits expansion of the fibrotic reaction triggered by TGFβ, FGF, and VEGF during myocardial healing \[[@CR31]\]. The high levels of activation of this chemokine in MSC (Table [3](#Tab3){ref-type="table"}) could account for the potent ability of these cells to control adverse remodeling during myocardial healing \[[@CR8], [@CR36], [@CR37]\].

Claudins are transmembrane proteins found in tight juntions that participate not only in regulating tissue barrier function and permeability but also in cell motility, adhesion and migration \[[@CR38]\]. Claudins (CLDN1 and CLDN14) were up-regulated in MSC after IL-1β treatment. A similar response has been reported in airway smooth muscle cells in response to IL-1β and TNFα \[[@CR39]\], indicating similar activation pathways. It has been described that TLR signalling is linked to NF-κB and MAPK signalling pathways, and that this induction mediates the secretion chemokines and regulates immunosuppressive activity and recruitment of innate immune cells \[[@CR21], [@CR40], [@CR41]\]. TLR2 and TLR4 were up-regulated in response to IL-1β. Similar effect had been previously described after stimulation with LPS of MSC from human parotid glands \[[@CR42]\].

We also found differences between the activation pattern of MSC in response to different inflammatory mediators. Whereas TNFα increased preferentially CCL2 (MCP-1), CCL5 (RANTES), CXCL1, CXCL5, CXCL8, CXCL10 and CCL11 \[[@CR10]\], we demonstrate here that IL-1β increases preferentially CCL3, CCL5, CCL20, CXCL1,CXCL3, CXCL10 and CXCL11. Thus, modulation of MSC biological responses is closely associated with culture conditions and the presence of immune mediators influence MSC proliferation and multipotency. In this context, culture protocols with milieu capable of MSC expansion while preserving chromosome stability have been developed \[[@CR43]\]

In summary, our findings show that IL-1β increases migration and adhesion of MSC and promotes leucocyte chemotaxis through MSC secretion of soluble factors. As described in other cell types \[[@CR44]\], IL-1β activates NF-κB resultings in transcriptional activation of a wide variety of genes such inflammatory mediators, adhesion molecules, growth factor or immune response mediator. Since some of these molecules are chemotactic for inflammatory leukocytes, like monocytes and neutrophils, these paracrine factors could facilitate infiltration of immune cells for tissue repair when MSC are transplanted into injured tissues.

Taken together, these findings shed light on MSC behaviour in inflammatory environments and suggest that inflammatory mediators like IL-1β induce a response in MSC that could trigger paracrine actions *in vivo*.
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Table S1Identification of genes from enriched biological processes up-regulated in MSC-IL1β. Fold changes were calculated between two experimental conditions as log 2 transformation of the ratio between MSC and MSC-IL1β. Systematic name, gene symbol and description of genes with significant changes are indicated. Minus values of fold change (Fc) indicate up-regulation in MSC-IL1β. (DOC 874 kb)
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